海外推奨論文紹介
この度、国際化推進ワーキンググループの活動の一環として、海外からの論文の中で会員は是非読んでいただきたいと思うものをピックアップし、その論文を簡単にご紹介することを開始致しました。
（眼炎症学会国際化推進ワーキンググループ）
委員長 南場研一
委 員 丸山和一、竹内正樹、坪田欣也、松宮 亘、岩橋千春、鈴木佳代
■2024年3月～2024年6月までに発表された論文の中から5報ご紹介いたします。
1. Childhood Chronic Idiopathic Uveitis in a Multicenter International Cohort
Maccora I, Guly C, de Libero C, Caputo R, Ramanan AV, Simonini G.
Ocul Immunol Inflamm. 2024;32(3):310-319.
PMID: 36802984 DOI: 10.1080/09273948.2023.2169715
2. XEN®-45 implantation for refractory uveitic glaucoma
Evers C, Anton A, Böhringer D, Kallee S, Keye P, Neß T, Philippin H, Reinhard T, Lübke J.
Graefes Arch Clin Exp Ophthalmol. 2024 Mar;262(3):937-948. doi: 10.1007/s00417-023-
06254-3. Epub 2023 Oct 19. PMID: 37855957; PMCID: PMC10907455.
3. Accuracy of an Artificial Intelligence Chatbot’s Interpretation of Clinical Ophthalmic Images.
Mihalache A, Huang RS, Popovic MM, Patil NS, Pandya BU, Shor R, Pereira A, Kwok JM,
Yan P, Wong DT, Kertes PJ, Muni RH.
JAMA Ophthalmol. 2024 Apr 1;142(4):321-326. doi: 10.1001/jamaophthalmol.2024.0017.
PMID: 38421670
4. Clinical Efficacy of Biosimilar Switch of Adalimumab for Management of Uveitis
Murray GM, Griffith N, Sinnappurajar P, Al Julandani DA, Clarke SLN, Hawley DP, Choi J,
Guly CM, Ramanan AV.
Ocul Immunol Inflamm. 2024 May;32(4):442-446.
Guo S, Hu R, Wang M, Xia L, Yang P.
Ocul Immunol Inflamm. Published online June 25, 2024.
doi:10.1080/09273948.2024.2369940
■2023年11月～2024年2月までに発表された論文の中から4報ご紹介いたします。
1. Long-term visual acuity outcomes following cataract surgery in eyes with ocular inflammatory
disease
Gangaputra S, Newcomb C, Armour R, Choi D, Ying GS, Groth S, Begum H, Fitzgerald T,
Artornsombudh P, Daniel E, Bhatt N, Foster S, Jabs D, Levy-Clarke G, Nussenblatt R,
Rosenbaum JT, Sen HN, Suhler E, Thorne J, Dreger K, Buchanich J, Kempen JH; Systemic
Immunosuppressive Therapy for Eye Diseases (SITE) Research Group.
Br J Ophthalmol. 2024 Feb 21;108(3):380-385. doi: 10.1136/bjo-2022-322236.
2. Rising Incidence of Syphilitic Uveitis-Related Hospitalizations in the US
Mir, T. A., Kim, S. J., Fang, W., Harvey, J. & Hinkle, D. M., JAMA ophthalmology 2023 142,
7-14, PMID: 37991790 DOI: :10.1001/jamaophthalmol.2023.53.
3. A large meta-analysis identifies genes associated with anterior uveitis.
Gelfman, S. et al. Nature communications 14, 7300, doi:10.1038/s41467-023-43036-1 (2023).
Sener, H., Evereklioglu, C., Horozoglu, F. & Gunay Sener, A. B. 32, 89-97, doi:10.1080/09273948.2022.2157288 (2024).
■2023年7月～2023年10月までに発表された論文の中から5報ご紹介いたします。
1. Risk of Noninfectious Uveitis after Coronavirus Disease 2019 Vaccination in a United States Claims Database.
Kumar A, Miller DC, Sun Y, Arnold BF, Acharya NR.
Ophthalmology. 2023 Jul 20:S0161-6420(23)00502-X.
2. THE HUMIRA IN OCULAR INFLAMMATIONS TAPER (HOT) STUDY.
Pichi F, Smith SD, Goldstein DA, Baddar D, Gerges TKA, Janetos TM, Ruiz-Cruz M, Concha-Del-Río LE, Maruyama K, Carina Ten Berge J, Rombach SM, Cimino L, Bolletta E, Miserocchi E, Scandale P, Serafino M, Camicione P, Androudi S, Gonzalez-Lopez JJ, Lim LL, Singh N, Gupta V, Gupta N, Amer R, Md EMD, Md SI, Munk MR, Donicova E, Carreño E, Takeuchi M, Chee SP, Chew MC, Agarwal A, Schlaen A, Gómez RA, Couto CA, Khairallah M, Neri P.
Am J Ophthalmol. 2023 Sep 19:S0002-9394(23)00377-X.
3. Non-infectious uveitis risk after Coronavirus Disease 2019 (COVID-19) vaccination: A nationwide retrospective cohort study.
Chang MS, Kim HR, Kim S, Lee CS, Byeon SH, Kim SS, Lee SW, Kim YJ.
Am J Ophthalmol. 2023 Sep 20:S0002-9394(23)00381-1.
4. Drug-induced uveitis related to Checkpoint inhibitors and MAPkinase inhibitors.
Thibault T, Ben Ghezala I, Freppel R, Rajillah A, Boulay C, Brunel P, Atzenhoffer M, Auvens C, Devilliers H, Grandvuillemin A.
Ophthalmology. 2023 Oct 9:S0161-6420(23)00716-9.
5.Comparison of intestinal microbes and metabolites in active VKH versus acute anterior uveitis associated with ankylosing spondylitis.
Li M, Liu M, Wang X, Wei H, Jin S, Liu X.
Br J Ophthalmol. 2023 Oct 11:bjo-2023-324125.
■2023年3月～2023年6月までに発表された論文の中から5報ご紹介いたします。
1. Navigating Coronavirus Disease 2019 Vaccination and Uveitis: Identifying the Rates and Risk of Recurrent Uveitis after Coronavirus Disease Vaccination
Charlotte A Jordan, Stephanie Townend, Natalie Allen, Joanne Sims, Charles N J McGhee, Rachael L Niederer
Ophthalmology. 2023 May;130(5):501-508.
doi: 10.1016/j.ophtha.2022.12.013.
2. The role of the retinal nerve fiber layer thickness on OCT in the evaluation of papillitis in childhood uveitis: Evaluating papillitis in pediatric uveitis using OCT-RNFL
Carlyn V Kouwenberg, Laurens A Blom, Suzanne C Vellinga, Irem Bozkir, Joke H de
Boer, Viera Koopman-Kalinina Ayuso
Am J Ophthalmol. 2023 May 4;S0002-9394(23)00199-X.
doi: 10.1016/j.ajo.2023.05.006.
3. Intravitreal Therapy for Uveitic Macular Edema-Ranibizumab versus Methotrexate versus the Dexamethasone Implant: The MERIT Trial Results
Multicenter Uveitis Steroid Treatment Trial (MUST) Research Group, Writing Committe:; Nisha R Acharya, Albert T Vitale, Elizabeth A Sugar, Janet T Holbrook, Alyce E Burke, Jennifer E Thorne, Michael M Altaweel, John H Kempen, Douglas A Jabs
Ophthalmology. 2023 May 24;S0161-6420(23)00254-3.
doi: 10.1016/j.ophtha.2023.04.011.
4. Usefulness of the QuantiFERON test for the diagnosis of tubercular uveitis and the predictions of response to antituberculosis treatment
Danjou W, Pradat P, Jamilloux Y, Gerfaud-Valentin M, Kodjikian L, Trad S, Seve P.
Br J Ophthalmol. 2023 Apr;107(4):500-504.
doi: 10.1136/bjophthalmol-2021-318868. Epub 2021 Oct 28.
5. Comparison of Uveitis Incidence by Medication in Juvenile Idiopathic Arthritis and Implications for Screening
Henry S Bison, Timothy M Janetos, Hans M Gao, David L Zhang, Jessica Song, Brenda L Bohnsack
Am J Ophthalmol. 2023 Mar;247:70-78.
doi: 10.1016/j.ajo.2022.11.010.
■2022年11月～2023年2月までに発表された論文の中から5報ご紹介いたします。
1. Antidrug Antibodies to Tumor Necrosis Factor α Inhibitors in Patients With Noninfectious Uveitis
Sunil Bellur , Matthew McHarg, Wijak Kongwattananon , Susan Vitale, H Nida Sen, Shilpa Kodati.
JAMA Ophthalmol. 2023 Feb 1;141(2):150-156. PMID: 36547953 PMCID: PMC9936342 DOI: 10.1001/jamaophthalmol.2022.5584
Virginia Miraldi Utz, Sheila T Angeles-Han, Najima Mwase, Amy Cassedy, Theresa Hennard, Daniel J Lovell, Sarah Lopper, Hermine I Brunner Eniolami O Dosunmu, Alexei A Grom, Michael Henrickson , Jennifer L Huggins, Robert A Sisk, Tracy V Ting, Adam H Kaufman.
Am J Ophthalmol. 2022 Dec;244:183-195. PMID: 35863492 DOI: 10.1016/j.ajo.2022.06.024
3.Cataract Surgery in Uveitis: Risk Factors, Outcomes, and Complications
Haya Husam Al-Ani, Joanne Lesley Sims, Rachael Louise Niederer
Am J Ophthalmol. 2022 Dec;244:117-124. DOI:https://doi.org/10.1016/j.ajo.2022.08.014
4. Cerebrospinal Fluid Interleukin-10 Biomarker for Vitreoretinal Lymphoma
Xiao Zhang, Yan Zhang, Zhe Zhuang, You-Xin Chen, Wei Zhang, Mei-fen Zhang
Am J Ophthalmol. 2023 Feb;246:242-250. DOI:https://doi.org/10.1016/j.ajo.2022.10.009
5. Implications of COVID-19 infection on patients with uveitis under biologic treatment
Abdulrahman F AlBloushi, Abdullah M Alfawaz, Ahmed M Abu El Asra.
Br J Ophthalmol. 2022 Nov;106(11):1538-1541. PMID: 33931386 PMCID: PMC8098233
DOI: 10.1136/bjophthalmol-2020-318577
■2022年7月～2022年11月までに発表された論文の中から5報ご紹介いたします。
Laura E M Eurelings, Tom O A R Missotten, Mirjam E J van Velthoven, Paul L A van Daele, Jan A M van Laar, P Martin van Hagen, Alberta A H J Thiadens, Saskia M Rombach
Am J Ophthalmol. 2022 Aug;240:194-204. doi: 10.1016/j.ajo.2022.03.017.
2. Better visual outcome associated with early vitrectomy in the management of endophthalmitis
Sarah Welch, Riyaz Bhikoo, Nancy Wang, Martin J Siemerink, William Shew, Philip J Polkinghorne, Rachael L Niederer
Br J Ophthalmol. 2022 Aug;106(8):1145-1149. doi: 10.1136/bjophthalmol-2020-316846.
3.Clinical Course and Outcome in Pediatric Idiopathic Chronic Anterior Uveitis
Carlyn V Kouwenberg, Roos A W Wennink, Mahfam Shahabi, Irem Bozkir, Viera Koopman-Kalinina Ayuso, Joke H de Boer
Am J Ophthalmol. 2022 Sep;241:198-205. doi: 10.1016/j.ajo.2022.04.015.
Lucas Sejournet, Sebastien Kerever, Thibaud Mathis, Laurent Kodjikian, Yvan Jamilloux, Pascal Seve
Br J Ophthalmol. 2022 Oct;106(10):1380-1386. doi: 10.1136/bjophthalmol-2021-319072.
Tomkins-Netzer O, Sar S, Barnett-Griness O, Friedman B, Shyriaieva H, Saliba W.
Ophthalmology. 2022 Oct;129(10):1087-1095. doi: 10.1016/j.ophtha.2022.05.015.
■2022年3月～2022年6月までに発表された論文の中から4報ご紹介いたします。
ぶどう膜炎におけるインフリキシマブとアダリムマブによる再発率の低下：330症例の多施設共同研究
Maalouf G, Andrillon A, Leclercq M, Sève P, Bielefeld P, Gueudry J, Sené T,
Titah C, Moulinet T, Rouvière B, Sène D, Desbois AC, Domont F, Touhami S,
Thibault T, Chamieh CE, Cacoub P, Kodjikian L, Biard L, Bodaghi B, Saadoun D.
Am J Ophthalmol. 2022 Jun;238:173-180. doi: 10.1016/j.ajo.2022.02.002. Epub 2022 Feb 13.
PMID: 35172172.
Tsui E, Rathinam SR, Gonzales JA, Thundikandy R, Kanakath A, Balamurugan S,
Vedhanayaki R, Lim LL, Suhler EB, Al-Dhibi HA, Doan T, Keenan J, Ebert CD, Kim
E, Madow B, Porco TC, Acharya NR; FAST Research Group.
Ophthalmology. 2022 Jun;129(6):661-667. doi: 10.1016/j.ophtha.2022.02.002. Epub 2022 Feb 8.
PMID: 35143800.
3.Advanced OCT Analysis of Biopsy-proven Vitreoretinal Lymphoma
Pichi F, Dolz-Marco R, Francis JH, Au A, Davis JL, Fawzi A, Gattousi S,
Goldstein DA, Keane PA, Miserocchi E, Marchese A, Ohno-Matsui K, Sagoo MS, Smith
SD, Sobol EK, Tasiopoulou A, Yang X, Shields CL, Freund KB, Sarraf D.
Am J Ophthalmol. 2022 Jun;238:16-26. doi: 10.1016/j.ajo.2021.11.023. Epub 2021 Nov 27.
PMID: 34843686.
Leclercq M, Andrillon A, Maalouf G, Sève P, Bielefeld P, Gueudry J, Sené T, Moulinet T, Rouvière B, Sène D, Desbois AC, Domont F, Touhami S, El Chamieh C, Cacoub P, Bodaghi B, Biard L, Saadoun D.
Ophthalmology. 2022 May;129(5):520-529. doi: 10.1016/j.ophtha.2021.11.013. Epub 2021 Nov 16.
PMID: 34793830.